Infrastructure spending in Britain has dropped sharply since the vote to leave the EU,

with figure showing it decline by a fifth to 1.5 billion pounds in July.

The slowdown will put pressure on prime minister Theresa May

to push ahead with pledges for new road, rail, energy, broadband, and flood defence projects.

Pfizer, the US pharmaceutical group is nearing a deal with 14 billion dollars

to acquire California biotechnology company, Medivation.

The deal comes as a handful of its large rivals fight to win the auction

for the sought-after cancer drug maker.

And Google's parent, Alphabet, and Warren Buffett's Berkshire Hathaway

are topping a list of more than 800 US companies that could come under pressure to refresh their boards

under new guidelines being floated among shareholders.

ISS, the corporate governance advisor, is considering targeting companies

where boards are stuffed with long-serving directors,

or where there have been no new members for years.

For more of today's top stories, go to FT.com/firstft